Figure and Table | Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn’s Disease: A Retrospective Study

Figure 1. Diagnostic accuracy of LRG based on receiver operating characteristic curve analysis for endoscopic activity.
AUC: area under the curve; CI: confidence interval; FPF: false positive fraction; LRG: leucine-rich α-2 glycoprotein; TPF: true positive fraction.

From: Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn’s Disease: A Retrospective Study

» Back to article page

Figure 2. The median level of serum LRG and the percentage below the cutoff value, stratified by the mSES-CD.
IQR: interquartile range; LRG: leucine-rich α-2 glycoprotein; mSES-CD: modified Simple Endoscopic Score for Crohn’s disease.

From: Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn’s Disease: A Retrospective Study

» Back to article page

Figure 3. Kaplan-Meier analysis of hospitalization-free survival between low and high LRG groups.
CI: confidence interval; LRG: leucine-rich α-2 glycoprotein.

From: Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn’s Disease: A Retrospective Study

» Back to article page

Figure 4. Kaplan-Meier analysis of surgery-free survival between low and high LRG groups.
CI: confidence interval; LRG: leucine-rich α-2 glycoprotein.

From: Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn’s Disease: A Retrospective Study

» Back to article page